Our results reinforce the latest recommendation of avoiding glucocorticoid use in COVID-19 clients not enduring hypoxemia (17,18). More critically, we identified that the cumulative glucocorticoid dose is also a contributory element for CAM.
Also visit my homepage
Highly recommended Site